Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette
$ 10.99 · 5 (250) · In stock
A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell disease, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center reported in the Journal of Clinical Investigation.
FDA approval of gene therapies for sickle cell disease: Q&A with NHLBI Director Dr. Gary Gibbons and NHLBI's Division of Blood Diseases and Resources Director Dr. Julie Panepinto
SEC Filing CRISPR Therapeutics
20-F
Gene therapy: Erasing sickle-cell disease
New study shows promising evidence for sickle cell gene therapy - UChicago Medicine
The Triple Helix F2017 by Kaley Brauer - Issuu
Gene therapy for sickle cell disease: moving from the bench to the bedside - ScienceDirect
Health Archives — Page 34 of 107 — Harvard Gazette
Salk Institute The Stem Cellar
CRISPR Sickle Cell Gene Therapy: Approaches, Challenges, and Progress
Health Archives — Page 34 of 107 — Harvard Gazette
The Stem Cellar, The Official Blog of CIRM, California's Stem Cell Agency
Health Archives — Page 34 of 107 — Harvard Gazette
CRISPR-based precision medicine for hematologic disorders: Advancements, challenges, and prospects - ScienceDirect
Health Archives — Page 34 of 107 — Harvard Gazette